Microangiopathic hemolytic anemia medical therapy

Jump to navigation Jump to search

Microangiopathic hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microangiopathic hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microangiopathic hemolytic anemia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microangiopathic hemolytic anemia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microangiopathic hemolytic anemia medical therapy

on Microangiopathic hemolytic anemia medical therapy

Microangiopathic hemolytic anemia medical therapy in the news

Blogs on Microangiopathic hemolytic anemia medical therapy

Directions to Hospitals Treating Microangiopathic hemolytic anemia

Risk calculators and risk factors for Microangiopathic hemolytic anemia medical therapy

Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]


References

  1. Arnold DM, Patriquin CJ, Nazy I (2017). "Thrombotic microangiopathies: a general approach to diagnosis and management". CMAJ. 189 (4): E153–E159. doi:10.1503/cmaj.160142. PMC 5266569. PMID 27754896.
  2. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC; et al. (1991). "Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group". N Engl J Med. 325 (6): 393–7. doi:10.1056/NEJM199108083250604. PMID 2062330.
  3. Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F; et al. (2012). "Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies". Br J Haematol. 158 (3): 323–35. doi:10.1111/j.1365-2141.2012.09167.x. PMID 22624596.
  4. Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN (2009). "Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura". Transfusion. 49 (5): 873–87. doi:10.1111/j.1537-2995.2008.02082.x. PMID 19210323.
  5. Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA (2015). "Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality". Blood. 125 (9): 1470–6. doi:10.1182/blood-2014-10-605493. PMC 4342358. PMID 25588677.
  6. George JN (2010). "How I treat patients with thrombotic thrombocytopenic purpura: 2010". Blood. 116 (20): 4060–9. doi:10.1182/blood-2010-07-271445. PMID 20686117.
  7. Bobbio-Pallavicini E, Gugliotta L, Centurioni R, Porta C, Vianelli N, Billio A; et al. (1997). "Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP". Haematologica. 82 (4): 429–35. PMID 9299856.
  8. Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO; et al. (2016). "Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial". Am J Kidney Dis. 68 (1): 84–93. doi:10.1053/j.ajkd.2015.12.034. PMID 27012908.
  9. Prior DJ (1975). "A study of the electrophysiological properties of the incurrent siphonal valve muscle of the surf clam, Spisula solidissima". Comp Biochem Physiol A Comp Physiol. 52 (4): 607–10. doi:10.1016/s0300-9629(75)80009-0. PMID 0.1182/blood-2014-10-559211 Check |pmid= value (help).
  10. Balduini CL, Gugliotta L, Luppi M, Laurenti L, Klersy C, Pieresca C; et al. (2010). "High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study". Ann Hematol. 89 (6): 591–6. doi:10.1007/s00277-009-0877-5. PMID 20033409.

Template:WH Template:WS